Atlas Trials

A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Clinical trial NCT00090532 · TERMINATED

Trial details

NCT number
NCT00090532
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Age-Related Macular Degeneration
Start date
2004-01-01
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.